PMC:7534795 / 655-932 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"T10","span":{"begin":207,"end":215},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or therapies for COVID-19. Accordingly, cardiovascular protective and supportive therap"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T50540","span":{"begin":0,"end":15},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or therapies for COVID-19. Accordingly, cardiovascular protective and supportive therap"}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":150,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or therapies for COVID-19. Accordingly, cardiovascular protective and supportive therap"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":38,"end":54},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0025464"}],"text":"immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or therapies for COVID-19. Accordingly, cardiovascular protective and supportive therap"}

{"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":140,"end":148},"obj":"Species"},{"id":"56","span":{"begin":17,"end":33},"obj":"Disease"},{"id":"57","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"58","span":{"begin":207,"end":215},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D019851"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:C000657245"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"immune response, hypercoagulation and oxidative stress, which contribute significantly to poor cardiovascular outcomes observed in COVID-19 patients. To date, there are no approved vaccines or therapies for COVID-19. Accordingly, cardiovascular protective and supportive therap"}